New and Generic Drug Approvals
Links shared publicly online about this topic.
- 380total visits
New and Generic Drug Approvals
fda.gov —
View full resource at fda.gov
Tags: Drug, Pharma, Biotech, FDA, News
Most Recently Shared on September 15, 2011 at 12:10 pm By:
Whole raft of generics firms get OK for copycat versions of UCB seizure drug Keppra XR http://t.co/iRRb7KrL
Also Shared By:
Report: FDA strengthens monitoring of post-approval drug safety
fda.gov — “A strengthened and modernized postmarket drug safety program has resulted in a substantial improvement in the U.S. Food and Drug Administration’s oversight of drugs once they reach the American public, according to a new report released today by the agency’s Center for Drug Evaluation and Research (CDER). The report, “Advances in FDA’s Safety Program for Marketed Drugs,” describes new scientific tools and enhanced capabilities that give the same priority to postmarket drug safety monitoring as t” View full resource at fda.gov
Most Recently Shared on April 21, 2012 at 8:42 pm By:
HealthTrendster Health Executive
Report: FDA strengthens monitoring of post-approval drug safety: A strengthened and… http://t.co/Nlax6RLR
EU agency endorses Bristol, Astra diabetes drug | Reuters
reuters.com — “LONDON (Reuters) - European regulators on Friday backed approval of a new diabetes drug from AstraZeneca and Bristol-Myers Squibb that was rejected last year in the United States.Dapagliflozin belongs” View full resource at reuters.com
Most Recently Shared on April 20, 2012 at 2:07 pm By:
EU agency endorses Bristol, Astra diabetes drug: LONDON (Reuters) - European regulators on Friday backed approva... http://t.co/EeIYYqhz
EU agency endorses Bristol, Astra diabetes drug | Reuters
in.reuters.com — “LONDON (Reuters) - European regulators on Friday backed approval of a new diabetes drug from AstraZeneca and Bristol-Myers Squibb that was rejected last year in the United States.Dapagliflozin belongs” View full resource at in.reuters.com
Most Recently Shared on April 20, 2012 at 2:01 pm By:
EU agency endorses Bristol, Astra diabetes drug http://t.co/nNNLGw4j
Study finds high rates of off-label prescribing | Reuters
in.reuters.com — “NEW YORK (Reuters Health) - More than 10 percent of prescriptions in one Canadian province were for drugs not approved to treat the patient's condition, a new study finds. And many times, there was little” View full resource at in.reuters.com
Most Recently Shared on April 19, 2012 at 8:37 pm By:
Study finds high rates of off-label prescribing http://t.co/BkFNiIyM
Medgenics seeks IND approval to initiate EPODURE Biopump Phase IIb anemia study in ESRD patients
news-medical.net — “Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed an Investigational New Drug application with the U.S. Food and Drug Administration to initiate a Phase IIb multi-center, 100-patient clinical trial.” View full resource at news-medical.net
Most Recently Shared on April 18, 2012 at 4:01 pm By:
Diabetes News: Medgenics seeks IND approval to initiate EPODURE Biopump Phase IIb anemia study in ESRD patients:... http://t.co/ol32Ok8K
Abbott wins EU approval for new use of Humira drug | Reuters
reuters.com — “(Reuters) - Humira, the best-selling arthritis drug that forms the cornerstone of Abbott Laboratories' pharmaceutical business, has been approved in Europe for ulcerative colitis, the U.S. drugmaker said” View full resource at reuters.com
Most Recently Shared on April 11, 2012 at 6:12 am By:
Drugs and Devices OW OW Health
Abbott wins EU approval for new use of Humira drug - Reuters: Abbott wins EU approval for new use of Humir... http://t.co/LSZvbDEi #drug
Can a Dirt-Cheap Diabetes Drug Fight Cancer? - Health News - Health.com
news.health.com — “By Anne Harding FRIDAY, April 6, 2012 (Health.com) — Each year billions of dollars are spent in the search to find new cancer drugs. Very few of these would-be treatments end up being approved by the government and entering widespread use, which makes it all the more intriguing that one of the ...” View full resource at news.health.com
Most Recently Shared on April 6, 2012 at 10:40 pm By:
Can a Dirt-Cheap Diabetes Drug Fight Cancer?: FRIDAY, April 6, 2012 (http://t.co/TuSWYJq4) — Each year billions o... http://t.co/eMk00plc
New diet drug Qnexa awaits FDA approval amid safety questions – USATODAY.com
usatoday.com — “Some experts say it could potentially help dieters lose about 10% of their weight, but with its former FDA rejection, how safe is it?” View full resource at usatoday.com
Most Recently Shared on April 4, 2012 at 10:45 pm By:
Diet drug Qnexa awaits FDA approval amid safety questions http://t.co/YjlUT7Bn
Teva Jumps as New Drugs Bolster Outlook: Israel Overnight - Bloomberg
bloomberg.com — “Teva Pharmaceutical Industries Ltd. extended its best start to a year since 2010 as exclusive rights to sell two medications boosted prospects U.S. sales for the world’s largest maker of generic drugs will recover in 2012.” View full resource at bloomberg.com
Most Recently Shared on April 3, 2012 at 12:17 pm By:
Teva benefits from exclusives on generic Avapro, Avalide. Provigil and Seroquel copies don't hurt, either http://t.co/v1mrcc1s #pharma
Consumer Reports Warns of Lax Testing for Medical Devices - ABC News
abcnews.go.com — “Consumer Reports advises patients to do their homework before having medical devices implanted in their bodies. Companies that sell defibrillators, stents or other such products can get approval from the Food and Drug Administration without their undergoing rigorous testing, Consumer Reports warned in a new report. The FDA collects information on medical device malfunctions that lead to death. Data highlighted by Consumer Reports show 686 deaths from 2009 to last year connected to automate” View full resource at abcnews.go.com
Most Recently Shared on March 29, 2012 at 7:39 pm By:
HealthIT Policy Health IT and Health News
Consumer Reports Warns of Lax Testing for Medical Devices: Consumer Reports advises patients to do their homewor... http://t.co/z5sM68RZ
Amgen Loses Monopoly on Drug for Dialysis Patients - NYTimes.com
nytimes.com — “The Food and Drug Administration approved a new anemia drug called Omontys for dialysis patients, which will end Amgen’s 24-year monopoly led by its Epogen drug.” View full resource at nytimes.com
Most Recently Shared on March 28, 2012 at 7:47 pm By:
Amgen Loses Monopoly on Drug for Dialysis Patients - http://t.co/O6kMuGDy #pharma
Amgen Loses Monopoly on Drug for Dialysis Patients - NYTimes.com
nytimes.com — “The Food and Drug Administration approved a new anemia drug called Omontys for dialysis patients, which will end Amgen’s 24-year monopoly led by its Epogen drug.” View full resource at nytimes.com
Most Recently Shared on March 28, 2012 at 6:19 pm By:
Daniel Kraft Physician, Doctor, Pediatrician, Internist, and Health Executive
NYTimes: F.D.A. Approves New Anemia Drug http://t.co/WJKYbgWZ
Amgen Loses Monopoly on Drug for Dialysis Patients - NYTimes.com
nytimes.com — “The Food and Drug Administration approved a new anemia drug called Omontys for dialysis patients, which will end Amgen’s 24-year monopoly led by its Epogen drug.” View full resource at nytimes.com
Most Recently Shared on March 28, 2012 at 10:51 am By:
Kent Bottles, MD Physician, Doctor, and Pathologist
Amgen Loses Monopoly on Drug for Dialysis Patients: http://t.co/AEiXXAfM
Amgen Loses Monopoly on Drug for Dialysis Patients - NYTimes.com
nytimes.com — “The Food and Drug Administration approved a new anemia drug called Omontys for dialysis patients, which will end Amgen’s 24-year monopoly led by its Epogen drug.” View full resource at nytimes.com
Most Recently Shared on March 28, 2012 at 1:16 am By:
FDA Approves New Anemia Drug http://t.co/Auh0ppSW
Amgen Loses Monopoly on Drug for Dialysis Patients - NYTimes.com
nytimes.com — “The Food and Drug Administration approved a new anemia drug called Omontys for dialysis patients, which will end Amgen’s 24-year monopoly led by its Epogen drug.” View full resource at nytimes.com
Most Recently Shared on March 27, 2012 at 7:30 pm By:
HealthTrendster Health Executive
F.D.A. Approves New Anemia Drug - A new anemia drug provides a less expensive alternative for dialysis patients and ... http://t.co/9YfRzcyE
Advertisement
Richard G. Lanzara
@rlanzara
RT @ACI_C5Pharma FDA News: New and Generic Drug Approvals http://1.usa.gov/ciZg7U #pharma #biotech
1 year ago...